RW

Robert Watson

Managing Partner at Gyrus Capital

📍 Geneva, Geneva, Switzerland🔄 Updated September 2026💼 4 investments📅 11 years investing🗓 Last invested Jul 2018
VC🌍 Switzerland
4
Total investments
0
Early stage
1
Mid stage
0
Late stage
11y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jul 2018
ReBio Pharma is a pre-clinical stage biotechnology company that has developed SiSu®, a novel, proprietary formulation technology that solves the safety and efficacy challenges other sustained release approaches have been unable to resolve. SiSu® is designed to steadily release effective levels of therapeutics within the eye while safely dissolving once drug release is completed, and can be tuned to the drug, indication, and duration of release required. ReBio Pharma is leveraging Sisu® to create a new franchise to transform the standard of care for the millions of patients around the world living with chronic eye disease. Discover more at www.rebiopharma.com
mid stageBiotechnology
Board Member
Jun 2015
CMP Pharma, Inc. is a pharmaceuticals company based out of 8026 US Highway 264A, Farmville, North Carolina, United States.
Experience · 8 entries
All (8)
Investments (4)
Board (4)
2019
Managing Partner
Jan 2019
Gyrus is a private equity firm dedicated to transformational investments. We focus on sectors with strong, sustainable growth and investment opportunities where we can leverage our sector focus to support management to drive change and unlock value. Gyrus is based in Geneva, Switzerland.
2018
Board Member
Jul 2018
ReBio Pharma is a pre-clinical stage biotechnology company that has developed SiSu®, a novel, proprietary formulation technology that solves the safety and efficacy challenges other sustained release approaches have been unable to resolve. SiSu® is designed to steadily release effective levels of therapeutics within the eye while safely dissolving once drug release is completed, and can be tuned to the drug, indication, and duration of release required. ReBio Pharma is leveraging Sisu® to create a new franchise to transform the standard of care for the millions of patients around the world living with chronic eye disease. Discover more at www.rebiopharma.com
mid stageBiotechnology
2017
Board Member
Apr 2017
CCG (Chemical Computing Group) is a leading supplier of software solutions for life sciences. With a proven track record in scientific innovation, CCG continues to provide state of the art applications in drug discovery to pharmaceutical, biotechnology and academic researchers. CCG headquarters are in Montreal (Canada), with support offices in North America, Europe and Asia. CCG’s software programs include: 1) Molecular Operating Environment (MOE) - a single package for visualization, molecular modeling, computer-aided molecular design (CAMD), cheminformatics, bioinformatics and methodology development. 2) PSILO® - Protein SILO - a database system that provides an easily accessible, consolidated repository for macromolecular and protein-ligand structural information as well as a means to systematically track, register and search both experimental and computational macromolecular structural data. CCG has a strong academic presence with MOE and PSILO® being used extensively in teaching and research in over 600 universities world wide. CCG's special programs and discounts encourage the adoption of computational life science methodologies by the scientific community.
2015
Board Member
Jun 2015
CMP Pharma, Inc. is a pharmaceuticals company based out of 8026 US Highway 264A, Farmville, North Carolina, United States.
Board Member
Jan 2015
CSafe offers the most comprehensive suite of thermal shipping solutions for pharmaceutical cold chain shipping needs around the world. With a “client-first” focus, deep industry expertise and commitment to innovation, CSafe continues to deliver industry-leading products in both the active and passive segments. CSafe is the only provider with an end-to-end portfolio including active and passive bulk air cargo, parcel, cell and gene and specialty last-mile use cases allowing our team to match your requirements to the best solution for your needs. Offering nearly any size, duration and temperature – CSafe is At the Heart of Your Cold Chain.
Show all 8 entries ↓
Investment activity
2015–2018 · 4 investments
201522017120181
Recent (last 2 years)Earlier